|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|
| Net sales (Note 3) | |||
| Cost of sales | |||
| Gross profit | |||
| Operating expenses: | |||
| Selling, general and administrative | |||
| Goodwill impairment | |||
| Operating income (loss) | |||
| Other income (expense): | |||
| Interest income | |||
| Interest expense, net | |||
| Other, net | |||
| Income (loss) before taxes | |||
| Income tax benefit (expense) (Note 13) | |||
| Equity in earnings of affiliates | |||
| Net income (loss) | |||
| Net (income) loss attributable to redeemable non-controlling interests | |||
| Net income (loss) attributable to Covetrus | |||
| Earnings (loss) per share attributable to Covetrus: (Note 17) | |||
| Basic (in usd per share) | |||
| Diluted (in usd per share) | |||
| Weighted-average common shares outstanding: | |||
| Basic (in shares) | |||
| Diluted (in shares) |
Loading...
